| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 143, Issue 12 3949-3955, Copyright © 1989 by American Association of Immunologists
ARTICLES |
Y Horii, A Muraguchi, M Iwano, T Matsuda, T Hirayama, H Yamada, Y Fujii, K Dohi, H Ishikawa and Y Ohmoto
Division of Immunology, Osaka University, Japan.
In this study, we demonstrated that IL-6 was a possible autocrine growth factor for rat mesangial cells (MC). rIL-6 induced in vitro growth of rat MC at a concentration of 2 to 200 ng/ml and IL-6 activity was found in the supernatant of cultured rat MC. Northern blot analysis as well as in situ hybridization revealed that IL-6 mRNA was expressed in the cultured MC. Of urine samples from patients with mesangial proliferative glomerulonephritis (PGN) 50% were found to contain significant IL-6 activity (ranging from 30 to 126 pg/ml). Urine samples from other type of primary glomerular diseases such as minimal change nephrotic syndrome or healthy volunteers contained no detectable IL-6 activity. Only 2 of 27 urine samples from membranous nephropathy contained detectable amount of IL-6. Furthermore, there was some relationship between the levels of urine IL-6 and the progressive stage of PGN. Finally, by immunohistochemical staining using an anti-IL-6 mAb, it was shown that MC in the affected glomeruli of PGN patients produced IL-6, whereas MC obtained from the patients with membranous nephropathy, minimal change nephrotic syndrome or normal kidney were not found to produce IL-6. These data suggest that deregulated production of IL-6 is involved in PGN and the measurement of urine IL-6 is helpful for the differential diagnosis of PGN as well as for monitoring the progression of PGN.
This article has been cited by other articles:
|
|
 |
|
  V. R. Chowdhary, J. P. Grande, H. S. Luthra, and C. S. David Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus Rheumatology, September 1, 2007; 46(9): 1405 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, X. Chen, S. Shi, R. Wei, J. Wang, N. Yamanaka, and Q. Hong Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril Nephrol. Dial. Transplant., May 1, 2005; 20(5): 892 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. L. Zhang, N. Topley, T. Ito, and A. Phillips Interleukin-6 Regulation of Transforming Growth Factor (TGF)-{beta} Receptor Compartmentalization and Turnover Enhances TGF-{beta}1 Signaling J. Biol. Chem., April 1, 2005; 280(13): 12239 - 12245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Di Munno, M Mazzantini, A D. Sedie, M Mosca, and S Bombardieri Risk factors for osteoporosis in female patients with systemic lupus erythematosus Lupus, September 1, 2004; 13(9): 724 - 730. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Frosch, T. Vogl, R. Waldherr, C. Sorg, C. Sunderkotter, and J. Roth Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis J. Leukoc. Biol., February 1, 2004; 75(2): 198 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Marin, F. A. Montero-Julian, S. Gres, V. Boulay, P. Bongrand, C. Farnarier, and G. Kaplanski The IL-6-Soluble IL-6R{alpha} Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin J. Immunol., September 15, 2001; 167(6): 3435 - 3442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Koseki, C Terai, M Moriguchi, M Uesato, and N Kamatani A prospective study of renal disease in patients with early rheumatoid arthritis Ann Rheum Dis, April 1, 2001; 60(4): 327 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. JONES, S. HORIUCHI, N. TOPLEY, N. YAMAMOTO, and G. M. FULLER The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J, January 1, 2001; 15(1): 43 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nishimoto, T. Kishimoto, and K. Yoshizaki Anti-interleukin 6 receptor antibody treatment in rheumatic disease Ann Rheum Dis, November 1, 2000; 59(90001): i21 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ando, G. I. Perez-Perez, K. Kusugami, M. Ohsuga, K. C. Bloch, and M. J. Blaser Anti-CagA Immunoglobulin G Responses Correlate with Interleukin-8 Induction in Human Gastric Mucosal Biopsy Culture Clin. Vaccine Immunol., September 1, 2000; 7(5): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hess, H. Smola, U. Sandaradura de Silva, D. Hadaschik, D. Kube, S. E. Baldus, U. Flucke, and H. Pfister Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production J. Immunol., August 15, 2000; 165(4): 1939 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nishimoto, A. Ito, M. Ono, H. Tagoh, T. Matsumoto, T. Tomita, T. Ochi, and K. Yoshizaki IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor Int. Immunol., February 1, 2000; 12(2): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. GRASSL, B. LUCKOW, D. SCHLÖNDORFF, and U. DENDORFER Transcriptional Regulation of the Interleukin-6 Gene in Mesangial Cells J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1466 - 1477. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Launay, B. Grossetete, M. Arcos-Fajardo, E. Gaudin, S. P. Torres, L. Beaudoin, N. Patey-Mariaud de Serre, A. Lehuen, and R. C. Monteiro Fc{alpha} Receptor (CD89) Mediates the Development of Immunoglobulin A (IgA) Nephropathy (Berger's Disease): Evidence for Pathogenic Soluble Receptor-IgA Complexes in Patients and CD89 Transgenic Mice J. Exp. Med., June 6, 1999; 191(11): 1999 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ando, K. Kusugami, M. Ohsuga, K. Ina, M. Shinoda, T. Konagaya, T. Sakai, A. Imada, N. Kasuga, T. Nada, et al. Differential Normalization of Mucosal Interleukin-8 and Interleukin-6 Activity after Helicobacter pylori Eradication Infect. Immun., October 1, 1998; 66(10): 4742 - 4747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bihl, M. Tamm, M. Nauck, H. Wieland, A. P. Perruchoud, and M. Roth Proliferation of Human Non-Small-Cell Lung Cancer Cell Lines: Role of Interleukin-6 Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 606 - 612. [Abstract] [Full Text]
|
|
|
|
|
|
H. B. Richards, M. Satoh, M. Shaw, C. Libert, V. Poli, and W. H. Reeves Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus J. Exp. Med., September 7, 1998; 188(5): 985 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Peterson, A. Robertson, and W. Emlen Serum and urinary interleukin-6 in systemic lupus erythematosus Lupus, December 1, 1996; 5(6): 571 - 575. [Abstract] [PDF]
|
|
|
|
|
|
C. Gordon and P. Emery Cytokines and the Acute Phase Response in SLE Lupus, December 1, 1993; 2(6): 345 - 347. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
